Rheumatoid  ||| S:0 E:11 ||| JJ
arthritis  ||| S:11 E:21 ||| NN
and  ||| S:21 E:25 ||| CC
ankylosing  ||| S:25 E:36 ||| JJ
spondylitis  ||| S:36 E:48 ||| NN
-  ||| S:48 E:50 ||| :
pathology  ||| S:50 E:60 ||| NN
of  ||| S:60 E:63 ||| IN
acute  ||| S:63 E:69 ||| JJ
inflammation  ||| S:69 E:82 ||| JJ
Histomorphological  ||| S:82 E:101 ||| JJ
analysis  ||| S:101 E:110 ||| NN
of  ||| S:110 E:113 ||| IN
inflammatory  ||| S:113 E:126 ||| JJ
lesions  ||| S:126 E:134 ||| NNS
in  ||| S:134 E:137 ||| IN
rheumatoid  ||| S:137 E:148 ||| JJ
arthritis  ||| S:148 E:158 ||| NN
( ||| S:158 E:159 ||| -LRB-
RA ||| S:159 E:161 ||| NNP
)  ||| S:161 E:163 ||| -RRB-
and  ||| S:163 E:167 ||| CC
ankylosing  ||| S:167 E:178 ||| JJ
spondylitis  ||| S:178 E:190 ||| NNS
( ||| S:190 E:191 ||| -LRB-
AS ||| S:191 E:193 ||| NNP
)  ||| S:193 E:195 ||| -RRB-
display  ||| S:195 E:203 ||| NN
similarities  ||| S:203 E:216 ||| NNS
but  ||| S:216 E:220 ||| CC
also  ||| S:220 E:225 ||| RB
major  ||| S:225 E:231 ||| JJ
differences ||| S:231 E:242 ||| NNS
.  ||| S:242 E:244 ||| .
Ankylosing  ||| S:244 E:255 ||| JJ
spondylitis  ||| S:255 E:267 ||| NN
is  ||| S:267 E:270 ||| VBZ
characterised  ||| S:270 E:284 ||| VBN
by  ||| S:284 E:287 ||| IN
two  ||| S:287 E:291 ||| CD
key  ||| S:291 E:295 ||| JJ
pathological  ||| S:295 E:308 ||| JJ
findings ||| S:308 E:316 ||| NNS
:  ||| S:316 E:318 ||| :
sacroiliac  ||| S:318 E:329 ||| JJ
joint  ||| S:329 E:335 ||| JJ
and  ||| S:335 E:339 ||| CC
spinal  ||| S:339 E:346 ||| JJ
inflammation  ||| S:346 E:359 ||| NN
and  ||| S:359 E:363 ||| CC
new  ||| S:363 E:367 ||| JJ
bone  ||| S:367 E:372 ||| NN
formation  ||| S:372 E:382 ||| NN
with  ||| S:382 E:387 ||| IN
the  ||| S:387 E:391 ||| DT
possible  ||| S:391 E:400 ||| JJ
consequence  ||| S:400 E:412 ||| NN
of  ||| S:412 E:415 ||| IN
bone  ||| S:415 E:420 ||| NN
fusion ||| S:420 E:426 ||| NN
,  ||| S:426 E:428 ||| ,
usually  ||| S:428 E:436 ||| RB
in  ||| S:436 E:439 ||| IN
the  ||| S:439 E:443 ||| DT
axial  ||| S:443 E:449 ||| JJ
skeleton ||| S:449 E:457 ||| NN
.  ||| S:457 E:459 ||| .
In  ||| S:459 E:462 ||| IN
AS  ||| S:462 E:465 ||| IN
the  ||| S:465 E:469 ||| DT
primary  ||| S:469 E:477 ||| JJ
site  ||| S:477 E:482 ||| NN
of  ||| S:482 E:485 ||| IN
inflammation  ||| S:485 E:498 ||| NN
is  ||| S:498 E:501 ||| VBZ
located  ||| S:501 E:509 ||| VBN
at  ||| S:509 E:512 ||| IN
the  ||| S:512 E:516 ||| DT
enthesis  ||| S:516 E:525 ||| NN
or  ||| S:525 E:528 ||| CC
subchondral  ||| S:528 E:540 ||| JJ
bone  ||| S:540 E:545 ||| NN
marrow  ||| S:545 E:552 ||| NN
with  ||| S:552 E:557 ||| IN
bone  ||| S:557 E:562 ||| NN
marrow  ||| S:562 E:569 ||| NN
oedema ||| S:569 E:575 ||| NN
,  ||| S:575 E:577 ||| ,
lymphocytic  ||| S:577 E:589 ||| JJ
infiltrates ||| S:589 E:600 ||| NN
,  ||| S:600 E:602 ||| ,
increased  ||| S:602 E:612 ||| VBD
osteoclast  ||| S:612 E:623 ||| JJ
density  ||| S:623 E:631 ||| NN
and  ||| S:631 E:635 ||| CC
increased  ||| S:635 E:645 ||| VBD
microvessel  ||| S:645 E:657 ||| JJ
density  ||| S:657 E:665 ||| NNS
are  ||| S:665 E:669 ||| VBP
typical  ||| S:669 E:677 ||| JJ
findings  ||| S:677 E:686 ||| NNS
in  ||| S:686 E:689 ||| IN
acute  ||| S:689 E:695 ||| JJ
inflammation ||| S:695 E:707 ||| NN
.  ||| S:707 E:709 ||| .
In  ||| S:709 E:712 ||| IN
RA  ||| S:712 E:715 ||| NNP
joint  ||| S:715 E:721 ||| JJ
inflammation  ||| S:721 E:734 ||| NN
has  ||| S:734 E:738 ||| VBZ
its  ||| S:738 E:742 ||| PRP$
origin  ||| S:742 E:749 ||| NN
in  ||| S:749 E:752 ||| IN
the  ||| S:752 E:756 ||| DT
synovial  ||| S:756 E:765 ||| JJ
membrane  ||| S:765 E:774 ||| NN
of  ||| S:774 E:777 ||| IN
peripheral  ||| S:777 E:788 ||| JJ
joints ||| S:788 E:794 ||| NNS
.  ||| S:794 E:796 ||| .
Osteitis  ||| S:796 E:805 ||| NNP
in  ||| S:805 E:808 ||| IN
the  ||| S:808 E:812 ||| DT
subchondral  ||| S:812 E:824 ||| JJ
bone  ||| S:824 E:829 ||| NN
marrow  ||| S:829 E:836 ||| NN
reveals  ||| S:836 E:844 ||| VBZ
similar  ||| S:844 E:852 ||| JJ
findings  ||| S:852 E:861 ||| NNS
compared  ||| S:861 E:870 ||| VBN
to  ||| S:870 E:873 ||| TO
AS  ||| S:873 E:876 ||| NNP
and  ||| S:876 E:880 ||| CC
it  ||| S:880 E:883 ||| PRP
is  ||| S:883 E:886 ||| VBZ
suggested  ||| S:886 E:896 ||| VBN
to  ||| S:896 E:899 ||| TO
occur  ||| S:899 E:905 ||| VB
secondary  ||| S:905 E:915 ||| JJ
to  ||| S:915 E:918 ||| TO
inflammation  ||| S:918 E:931 ||| VB
in  ||| S:931 E:934 ||| IN
the  ||| S:934 E:938 ||| DT
synovial  ||| S:938 E:947 ||| JJ
membrane ||| S:947 E:955 ||| NN
.  ||| S:955 E:957 ||| .
Structural  ||| S:957 E:968 ||| JJ
damage  ||| S:968 E:975 ||| NN
defines  ||| S:975 E:983 ||| VBZ
the  ||| S:983 E:987 ||| DT
outcome  ||| S:987 E:995 ||| NN
in  ||| S:995 E:998 ||| IN
both  ||| S:998 E:1003 ||| DT
diseases ||| S:1003 E:1011 ||| NNS
.  ||| S:1011 E:1013 ||| .
However ||| S:1013 E:1020 ||| RB
,  ||| S:1020 E:1022 ||| ,
in  ||| S:1022 E:1025 ||| IN
AS  ||| S:1025 E:1028 ||| IN
it  ||| S:1028 E:1031 ||| PRP
is  ||| S:1031 E:1034 ||| VBZ
defined  ||| S:1034 E:1042 ||| VBN
by  ||| S:1042 E:1045 ||| IN
new  ||| S:1045 E:1049 ||| JJ
bone  ||| S:1049 E:1054 ||| NN
formation  ||| S:1054 E:1064 ||| NN
and  ||| S:1064 E:1068 ||| CC
in  ||| S:1068 E:1071 ||| IN
RA  ||| S:1071 E:1074 ||| NNP
by  ||| S:1074 E:1077 ||| IN
the  ||| S:1077 E:1081 ||| DT
destruction  ||| S:1081 E:1093 ||| NN
of  ||| S:1093 E:1096 ||| IN
cortical  ||| S:1096 E:1105 ||| JJ
bone ||| S:1105 E:1109 ||| NN
.  ||| S:1109 E:1111 ||| .
